Oral octreotide capsules lowered incidence and improved severity of acromegaly symptoms compared to injectable somatostatin receptor ligands—results from the MPOWERED trial
Key Points
Key points are not available for this paper at this time.
Abstract
no. PEP8.1
Demander à l'IA
Like
Bookmark
Share
Demander à l'IA
Like
Bookmark
Share
Oral octreotide capsules lowered incidence and improved severity of acromegaly symptoms compared to injectable somatostatin receptor ligands—results from the MPOWERED trial | Synapse